Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 14.08
+0.31 (2.25%)
At close: Jan 8, 2026
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 30.78 billion as of January 8, 2026. Its market cap has increased by 42.21% in one year.
Market Cap
30.78B
Enterprise Value
27.76B
Revenue
6.50B
Ranking
n/a
PE Ratio
1.26
Stock Price
14.08
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 30.78B, an increase of 1,357.48%. That is a compound annual growth rate of 30.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 30.78B | 13.37% |
| Dec 31, 2025 | 27.15B | 28.71% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 276.04B |
| Hansoh Pharmaceutical Group Company | 233.56B |
| JD Health International | 197.37B |
| Innovent Biologics | 153.24B |
| WuXi Biologics | 149.11B |
| Akeso | 119.01B |
| Sino Biopharmaceutical | 117.63B |
| CSPC Pharmaceutical Group | 104.27B |